R1 RCM Inc. (RCM)
NASDAQ: RCM
· Real-Time Price · USD
14.31
null (null%)
At close: Nov 18, 2024, 10:00 PM
undefined% (1D)
| Bid | n/a |
| Market Cap | 6.04B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | -102.21428571428571 |
| Forward PE | n/a |
| Analyst | Hold |
| Dividends | n/a |
| Ask | n/a |
| Volume | 0 |
| Avg. Volume (20D) | 0 |
| Open | undefined |
| Previous Close | undefined |
| Day's Range | 14.31 - 14.31 |
| 52-Week Range | 14.31 - 14.31 |
| Beta | 0.84 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for RCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsR1 RCM Inc. is scheduled to release its earnings on
May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · businesswire.com
Cosentus Invests in Accreda Healthcare Management — An Anesthesia-Exclusive RCM ProviderIRVINE, Calif.--(BUSINESS WIRE)---- $RCM #Accreda--Cosentus invests in Accreda, an anesthesia-exclusive RCM provider, enhancing coding accuracy, claims processing & revenue performance.